251
Views
100
CrossRef citations to date
0
Altmetric
Special Report

Vitamin D, the immune system and asthma

, , &
Pages 693-702 | Published online: 10 Jan 2014

References

  • Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: vitamin-D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol.179(4), 2060–2063 (2007).
  • Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin-D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch. Intern. Med.169(4), 384–390 (2009).
  • Karatekin G, Kaya A, Salihoglu O, Balci H, Nuhoglu A. Association of subclinical vitamin-D deficiency in newborns with acute lower respiratory infection and their mothers. Eur. J. Clin. Nutr.63(4), 473–477 (2007).
  • Laaksi I, Ruohola JP, Tuohimaa P et al. An association of serum vitamin-D concentrations < 40 nmol/l with acute respiratory tract infection in young Finnish men. Am. J. Clin. Nutr.86(3), 714–717 (2007).
  • Wayse V, Yousafzai A, Mogale K, Filteau S. Association of subclinical vitamin-D deficiency with severe acute lower respiratory infection in Indian children under 5 y. Eur. J. Clin. Nutr.58(4), 563–567 (2004).
  • Garland CF, Garland FC, Gorham ED et al. The role of vitamin-D in cancer prevention. Am. J. Public Health96(2), 252–261 (2006).
  • Giovannucci E, Liu Y, Rimm EB et al. Prospective study of predictors of vitamin-D status and cancer incidence and mortality in men. J. Natl Cancer Inst.98(7), 451–459 (2006).
  • Zhou W, Heist RS, Liu G et al. Circulating 25-hydroxyvitamin-D levels predict survival in early-stage non-small-cell lung cancer patients. J. Clin. Oncol.25(5), 479–485 (2007).
  • Gorham ED, Garland CF, Garland FC et al. Optimal vitamin-D status for colorectal cancer prevention: a quantitative meta analysis. Am. J. Prev. Med.32(3), 210–216 (2007).
  • Crew KD, Gammon MD, Steck SE et al. Association between plasma 25-hydroxyvitamin-D and breast cancer risk. Cancer Prev. Res. (Phila. Pa)2(6), 598–604 (2009).
  • Grant WB, Garland CF. The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res.26(4A), 2687–2699 (2006).
  • Cantorna MT. Vitamin-D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog. Biophys. Mol. Biol.92(1), 60–64 (2006).
  • Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet358(9292), 1500–1503 (2001).
  • Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum.50(1), 72–77 (2004).
  • Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin-D levels and risk of multiple sclerosis. JAMA296(23), 2832–2838 (2006).
  • Munger KL, Zhang SM, O’Reilly E et al. Vitamin-D intake and incidence of multiple sclerosis. Neurology62(1), 60–65 (2004).
  • Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC. Surveillance for asthma – United States, 1980–1999. MMWR Surveill. Summ.51(1), 1–13 (2002).
  • Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy59(5), 469–478 (2004).
  • Manicourt DH, Devogelaer JP. Urban tropospheric ozone increases the prevalence of vitamin-D deficiency among Belgian postmenopausal women with outdoor activities during summer. J. Clin. Endocrinol. Metab.93(10), 3893–3899 (2008).
  • Aligne CA, Auinger P, Byrd RS, Weitzman M. Risk factors for pediatric asthma. Contributions of poverty, race, and urban residence. Am. J. Respir. Crit. Care Med.162(3 Pt 1), 873–877 (2000).
  • Hannan MT, Litman HJ, Araujo AB et al. Serum 25-hydroxyvitamin-D and bone mineral density in a racially and ethnically diverse group of men. J. Clin. Endocrinol. Metab.93(1), 40–46 (2008).
  • Weitzman M, Byrd RS, Auinger P. Black and white middle class children who have private health insurance in the United States. Pediatrics104(1 Pt 2), 151–157 (1999).
  • Carter-Pokras OD, Gergen PJ. Reported asthma among Puerto Rican, Mexican–American, and Cuban children, 1982 through 1984. Am. J. Public Health83(4), 580–582 (1993).
  • Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am. J. Respir. Crit. Care Med.175(7), 661–666 (2007).
  • Shore SA, Fredberg JJ. Obesity, smooth muscle, and airway hyperresponsiveness. J. Allergy Clin. Immunol.115(5), 925–927 (2005).
  • Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin-D in obesity. Am. J. Clin. Nutr.72(3), 690–693 (2000).
  • Adams JS, Hewison M. Unexpected actions of vitamin-D: new perspectives on the regulation of innate and adaptive immunity. Nat. Clin. Pract. Endocrinol. Metab.4(2), 80–90 (2008).
  • Holick MF. Resurrection of vitamin-D deficiency and rickets. J. Clin. Invest.116(8), 2062–2072 (2006).
  • Holick MF. High prevalence of vitamin-D inadequacy and implications for health. Mayo Clin. Proc.81(3), 353–373 (2006).
  • Holick MF. Vitamin-D deficiency. N. Engl. J. Med.357(3), 266–281 (2007).
  • Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin-D for multiple health outcomes. Am. J. Clin. Nutr.84(1), 18–28 (2006).
  • Vieth R, Bischoff-Ferrari H, Boucher BJ et al. The urgent need to recommend an intake of vitamin-D that is effective. Am. J. Clin. Nutr.85(3), 649–650 (2007).
  • Hollis BW, Wagner CL, Drezner MK, Binkley NC. Circulating vitamin-D3 and 25-hydroxyvitamin-D in humans: an important tool to define adequate nutritional vitamin-D status. J. Steroid Biochem. Mol. Biol.103(3–5), 631–634 (2007).
  • Bhattacharyya AK. Nutritional rickets in the tropics. World Rev. Nutr. Diet67, 140–197 (1992).
  • Taha SA, Dost SM, Sedrani SH. 25-hydroxyvitamin-D and total calcium: extraordinarily low plasma concentrations in Saudi mothers and their neonates. Pediatr. Res.18(8), 739–741 (1984).
  • Marwaha RK, Tandon N, Reddy DR et al. Vitamin-D and bone mineral density status of healthy schoolchildren in northern India. Am. J. Clin. Nutr.82(2), 477–482 (2005).
  • Nehama H, Wientroub S, Eisenberg Z, Birger A, Milbauer B, Weisman Y. Seasonal variation in paired maternal-newborn serum 25-hydroxyvitamin-D and 24,25-dihydroxyvitamin-D concentrations in Israel. Isr. J. Med. Sci.23(4), 274–277 (1987).
  • Brehm JM, Celedon JC, Soto-Quiros ME et al. Serum vitamin-D levels and markers of severity of childhood asthma in Costa Rica. Am. J. Respir. Crit. Care Med.179(9), 765–71 (2009).
  • Hayward I, Stein MT, Gibson MI. Nutritional rickets in San Diego. Am. J. Dis. Child.141(10), 1060–1062 (1987).
  • Stein EM, Laing EM, Hall DB et al. Serum 25-hydroxyvitamin-D concentrations in girls aged 4–8 y living in the southeastern United States. Am. J. Clin. Nutr.83(1), 75–81 (2006).
  • Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin-D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin-D3 synthesis in human skin. J. Clin. Endocrinol. Metab.67(2), 373–378 (1988).
  • Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ. Prevalence of vitamin-D deficiency among healthy adolescents. Arch. Pediatr. Adolesc. Med.158(6), 531–537 (2004).
  • Thomas MK, Lloyd-Jones DM, Thadhani RI et al. Hypovitaminosis D in medical inpatients. N. Engl. J. Med.338(12), 777–783 (1998).
  • Scragg R, Camargo CA Jr. Frequency of leisure-time physical activity and serum 25-hydroxyvitamin-D levels in the US population: results from the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol.168(6), 577–586; discussion 587–591 (2008).
  • Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1,25-dihydroxyvitamin-D3 receptors in human leukocytes. Science221(4616), 1181–1183 (1983).
  • Adorini L, Penna G, Giarratana N et al. Dendritic cells as key targets for immunomodulation by vitamin-D receptor ligands. J. Steroid Biochem. Mol. Biol.89–90(1–5), 437–441 (2004).
  • Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin-D-mediated human antimicrobial response. Science311(5768), 1770–1773 (2006).
  • Sigmundsdottir H, Pan J, Debes GF et al. DCs metabolize sunlight-induced vitamin-D3 to ‘program’ T cell attraction to the epidermal chemokine CCL27. Nat. Immunol.8(3), 285–293 (2007).
  • Mahon BD, Wittke A, Weaver V, Cantorna MT. The targets of vitamin-D depend on the differentiation and activation status of CD4 positive T cells. J. Cell Biochem.89(5), 922–932 (2003).
  • Griffin MD, Xing N, Kumar R. Vitamin-D and its analogs as regulators of immune activation and antigen presentation. Annu. Rev. Nutr.23, 117–145 (2003).
  • Iho S, Kura F, Sugiyama H, Takahashi T, Hoshino T. The role of monocytes in the suppression of PHA-induced proliferation and IL 2 production of human mononuclear cells by 1,25-dihydroxyvitamin-D3. Immunol. Lett.11(5–6), 331–336 (1985).
  • Reichel H, Koeffler HP, Tobler A, Norman AW. 1 α,25-dihydroxyvitamin-D3 inhibits γ-interferon synthesis by normal human peripheral blood lymphocytes. Proc. Natl Acad. Sci. USA84(10), 3385–3389 (1987).
  • Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th)1/Th17 to a Th2 and regulatory T cell profile. J. Pharmacol. Exp. Ther.324(1), 23–33 (2008).
  • Tang J, Zhou R, Luger D et al. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J. Immunol.182(8), 4624–4632 (2009).
  • Louten J, Boniface K, de Waal Malefyt R. Development and function of Th17 cells in health and disease. J. Allergy Clin. Immunol.123(5), 1004–1011 (2009).
  • Holgate ST. Pathogenesis of asthma. Clin. Exp. Allergy38(6), 872–897 (2008).
  • Wittke A, Chang A, Froicu M et al. Vitamin-D receptor expression by the lung micro-environment is required for maximal induction of lung inflammation. Arch. Biochem. Biophys.460(2), 306–313 (2007).
  • Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A. 1α,25-dihydroxyvitamin-D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells. J. Immunol.167(9), 4974–4980 (2001).
  • Staeva-Vieira TP, Freedman LP. 1,25-dihydroxyvitamin-D3 inhibits IFN-γ and IL-4 levels during in-vitro polarization of primary murine CD4+ T cells. J. Immunol.168(3), 1181–1189 (2002).
  • Mattner F, Smiroldo S, Galbiati F et al. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin-D(3). Eur. J. Immunol.30(2), 498–508 (2000).
  • Overbergh L, Decallonne B, Waer M et al. 1α,25-dihydroxyvitamin-D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524–543). Diabetes49(8), 1301–1307 (2000).
  • Topilski I, Flaishon L, Naveh Y, Harmelin A, Levo Y, Shachar I. The anti-inflammatory effects of 1,25-dihydroxyvitamin-D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T-lymphocyte homing. Eur. J. Immunol.34(4), 1068–1076 (2004).
  • McGlade JP, Gorman S, Zosky GR et al. Suppression of the asthmatic phenotype by ultraviolet B-induced, antigen-specific regulatory cells. Clin. Exp. Allergy37(9), 1267–1276 (2007).
  • Matheu V, Back O, Mondoc E, Issazadeh-Navikas S. Dual effects of vitamin-D-induced alteration of Th1/Th2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. J. Allergy Clin. Immunol.112(3), 585–592 (2003).
  • Wittke A, Weaver V, Mahon BD, August A, Cantorna MT. Vitamin-D receptor-deficient mice fail to develop experimental allergic asthma. J. Immunol.173(5), 3432–3436 (2004).
  • Jirapongsananuruk O, Melamed I, Leung DY. Additive immunosuppressive effects of 1,25-dihydroxyvitamin-D3 and corticosteroids on Th1, but not Th2, responses. J. Allergy Clin. Immunol.106(5), 981–985 (2000).
  • Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1,25-dihydroxyvitamin-D3: preferential inhibition of Th1 functions. J. Nutr.125(6 Suppl.), 1704S–1708S (1995).
  • Urry Z, Xystrakis E, Richards DF et al. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1α,25-dihydroxyvitamin-D3 abrogates regulatory function. J. Clin. Invest.119(2), 387–398 (2009).
  • Thien R, Baier K, Pietschmann P, Peterlik M, Willheim M. Interactions of 1 α,25-dihydroxyvitamin-D3 with IL-12 and IL-4 on cytokine expression of human T-lymphocytes. J. Allergy Clin. Immunol.116(3), 683–689 (2005).
  • Pichler J, Gerstmayr M, Szepfalusi Z, Urbanek R, Peterlik M, Willheim M. 1 α,25(OH)2D3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatr. Res.52(1), 12–18 (2002).
  • Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT. Cytokine profile in patients with multiple sclerosis following vitamin-D supplementation. J. Neuroimmunol.134(1–2), 128–132 (2003).
  • Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1 α,25-dihydroxyvitamin-D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol.167(4), 1945–1953 (2001).
  • Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1α,25-dihydroxyvitamin-D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes51(5), 1367–1374 (2002).
  • Umetsu DT, Akbari O, Dekruyff RH. Regulatory T cells control the development of allergic disease and asthma. J. Allergy Clin. Immunol.112(3), 480–487; quiz 488 (2003).
  • Hawrylowicz CM, O’Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat. Rev. Immunol.5(4), 271–283 (2005).
  • Barrat FJ, Cua DJ, Boonstra A et al.In-vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med.195(5), 603–616 (2002).
  • Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol.19, 683–765 (2001).
  • Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J, Wenzel S. Interleukin-10 regulation in normal subjects and patients with asthma. J. Allergy Clin. Immunol.97(6), 1288–1296 (1996).
  • Henry E, Desmet CJ, Garze V et al. Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthma. J. Immunol.181(10), 7230–7242 (2008).
  • Nakagome K, Dohi M, Okunishi K et al.In vivo IL-10 gene delivery suppresses airway eosinophilia and hyperreactivity by down-regulating APC functions and migration without impairing the antigen-specific systemic immune response in a mouse model of allergic airway inflammation. J. Immunol.174(11), 6955–6966 (2005).
  • Presser K, Schwinge D, Wegmann M et al. Coexpression of TGF-β1 and IL-10 enables regulatory T cells to completely suppress airway hyperreactivity. J. Immunol.181(11), 7751–7758 (2008).
  • Koya T, Matsuda H, Takeda K et al. IL-10-treated dendritic cells decrease airway hyperresponsiveness and airway inflammation in mice. J. Allergy Clin. Immunol.119(5), 1241–1250 (2007).
  • Akbari O, Freeman GJ, Meyer EH et al. Antigen-specific regulatory T cells develop via the ICOS–ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med.8(9), 1024–1032 (2002).
  • Kearley J, Barker JE, Robinson DS, Lloyd CM. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J. Exp. Med.202(11), 1539–1547 (2005).
  • Makela MJ, Kanehiro A, Dakhama A et al. The failure of interleukin-10-deficient mice to develop airway hyperresponsiveness is overcome by respiratory syncytial virus infection in allergen-sensitized/challenged mice. Am. J. Respir. Crit. Care Med.165(6), 824–831 (2002).
  • van Scott MR, Justice JP, Bradfield JF, Enright E, Sigounas A, Sur S. IL-10 reduces Th2 cytokine production and eosinophilia but augments airway reactivity in allergic mice. Am. J. Physiol. Lung Cell. Mol. Physiol.278(4), L667–L674 (2000).
  • Grunstein MM, Hakonarson H, Leiter J et al. Autocrine signaling by IL-10 mediates altered responsiveness of atopic sensitized airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol.281(5), L1130–L1137 (2001).
  • Gorman S, Kuritzky LA, Judge MA et al. Topically applied 1,25-dihydroxyvitamin-D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes. J. Immunol.179(9), 6273–6283 (2007).
  • Spach KM, Nashold FE, Dittel BN, Hayes CE. IL-10 signaling is essential for 1,25-dihydroxyvitamin-D3-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol.177(9), 6030–6037 (2006).
  • Taher YA, van Esch BC, Hofman GA, Henricks PA, van Oosterhout AJ. 1α,25-dihydroxyvitamin-D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-β. J. Immunol.180(8), 5211–5221 (2008).
  • Heine G, Niesner U, Chang HD et al. 1,25-dihydroxyvitamin-D(3) promotes IL-10 production in human B cells. Eur. J. Immunol.38(8), 2210–2218 (2008).
  • Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-β regulation of immune responses. Annu. Rev. Immunol.24, 99–146 (2006).
  • Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin-D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am. J. Clin. Nutr.83(4), 754–759 (2006).
  • Hypponen E, Berry DJ, Wjst M, Power C. Serum 25-hydroxyvitamin-D and IgE – a significant but nonlinear relationship. Allergy64(4), 613–620 (2009).
  • Evans KN, Nguyen L, Chan J et al. Effects of 25-hydroxyvitamin-D3 and 1,25-dihydroxyvitamin-D3 on cytokine production by human decidual cells. Biol. Reprod.75(6), 816–822 (2006).
  • Nguyen M, Guillozo H, Garabedian M, Balsan S. Lung as a possible additional target organ for vitamin-D during fetal life in the rat. Biol. Neonate52(4), 232–240 (1987).
  • Nguyen M, Trubert CL, Rizk-Rabin M et al. 1,25-dihydroxyvitamin-D3 and fetal lung maturation: immunogold detection of VDR expression in pneumocytes type II cells and effect on fructose 1,6 bisphosphatase. J. Steroid Biochem. Mol. Biol.89–90(1–5), 93–97 (2004).
  • Nguyen TM, Guillozo H, Marin L et al. 1,25-dihydroxyvitamin-D3 receptors in rat lung during the perinatal period: regulation and immunohistochemical localization. Endocrinology127(4), 1755–1762 (1990).
  • Nguyen TM, Guillozo H, Marin L, Tordet C, Koite S, Garabedian M. Evidence for a vitamin-D paracrine system regulating maturation of developing rat lung epithelium. Am. J. Physiol.271(3 Pt 1), L392–L399 (1996).
  • Gereke M, Jung S, Buer J, Bruder D. Alveolar type II epithelial cells present antigen to CD4+ T cells and induce Foxp3+ regulatory T cells. Am. J. Respir. Crit. Care Med.179(5), 344–355 (2009).
  • Gaultier C, Harf A, Balmain N, Cuisinier-Gleizes P, Mathieu H. Lung mechanics in rachitic rats. Am. Rev. Respir. Dis.130(6), 1108–1110 (1984).
  • Rehan VK, Torday JS, Peleg S et al. 1A,25-dihydroxy-3-epi-vitamin-D3, a natural metabolite of 1α,25-dihydroxy vitamin-D3: production and biological activity studies in pulmonary alveolar type II cells. Mol. Genet. Metab.76(1), 46–56 (2002).
  • Phokela SS, Peleg S, Moya FR, Alcorn JL. Regulation of human pulmonary surfactant protein gene expression by 1α,25-dihydroxyvitamin-D3. Am. J. Physiol. Lung Cell. Mol. Physiol.289(4), L617–L626 (2005).
  • Raby BA, Silverman EK, Lazarus R, Lange C, Kwiatkowski DJ, Weiss ST. Chromosome 12q harbors multiple genetic loci related to asthma and asthma-related phenotypes. Hum. Mol. Genet.12(16), 1973–1979 (2003).
  • Poon AH, Laprise C, Lemire M et al. Association of vitamin-D receptor genetic variants with susceptibility to asthma and atopy. Am. J. Respir. Crit. Care Med.170(9), 967–973 (2004).
  • Vollmert C, Illig T, Altmuller J et al. Single nucleotide polymorphism screening and association analysis – exclusion of integrin β 7 and vitamin-D receptor (chromosome 12q) as candidate genes for asthma. Clin. Exp. Allergy34(12), 1841–1850 (2004).
  • Wjst M. Variants in the vitamin-D receptor gene and asthma. BMC Genet.6(1), 2 (2005).
  • Wjst M, Altmuller J, Faus-Kessler T, Braig C, Bahnweg M, Andre E. Asthma families show transmission disequilibrium of gene variants in the vitamin-D metabolism and signalling pathway. Respir. Res.7, 60 (2006).
  • Camargo CA Jr, Rifas-Shiman SL, Litonjua AA et al. Maternal intake of vitamin-D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am. J. Clin. Nutr.85(3), 788–795 (2007).
  • Devereux G, Litonjua AA, Turner SW et al. Maternal vitamin-D intake during pregnancy and early childhood wheezing. Am. J. Clin. Nutr.85(3), 853–859 (2007).
  • Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin-D and pulmonary function in the third national health and nutrition examination survey. Chest128(6), 3792–3798 (2005).
  • Hypponen E, Sovio U, Wjst M et al. Infant vitamin-D supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966. Ann. NY Acad. Sci.1037, 84–95 (2004).
  • Gale CR, Robinson SM, Harvey NC et al. Maternal vitamin-D status during pregnancy and child outcomes. Eur. J. Clin. Nutr.62(1), 68–77 (2008).
  • Wjst M, Dold S. Genes, factor X, and allergens: what causes allergic diseases? Allergy54(7), 757–759 (1999).
  • Xystrakis E, Kusumakar S, Boswell S et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J. Clin. Invest.116(1), 146–155 (2006).
  • Banerjee A, Damera G, Bhandare R et al. Vitamin-D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells. Br. J. Pharmacol.155(1), 84–92 (2008).
  • Bosse Y, Maghni K, Hudson TJ. 1α,25-dihydroxy-vitamin-D3 stimulation of bronchial smooth muscle cells induces autocrine, contractility, and remodeling processes. Physiol. Genomics29(2), 161–168 (2007).
  • Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med.161(5), 1501–1507 (2000).
  • Stein RT, Sherrill D, Morgan WJ et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet354(9178), 541–545 (1999).
  • Jackson DJ, Gangnon RE, Evans MD et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am. J. Respir. Crit. Care Med.178(7), 667–672 (2008).
  • Carroll KN, Hartert TV. The impact of respiratory viral infection on wheezing illnesses and asthma exacerbations. Immunol. Allergy Clin. North Am.28(3), 539–561, viii (2008).
  • Walker VP, Modlin RL. The vitamin-D connection to pediatric infections and immune function. Pediatr. Res. (2009) (Epub ahead of print).
  • El-Radhi AS, Majeed M, Mansor N, Ibrahim M. High incidence of rickets in children with wheezy bronchitis in a developing country. J. R. Soc. Med.75(11), 884–887 (1982).
  • Muhe L, Lulseged S, Mason KE, Simoes EA. Case–control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet349(9068), 1801–1804 (1997).
  • Najada AS, Habashneh MS, Khader M. The frequency of nutritional rickets among hospitalized infants and its relation to respiratory diseases. J. Trop. Pediatr.50(6), 364–368 (2004).
  • Hiemstra PS. The role of epithelial β-defensins and cathelicidins in host defense of the lung. Exp. Lung Res.33(10), 537–542 (2007).
  • Herr C, Shaykhiev R, Bals R. The role of cathelicidin and defensins in pulmonary inflammatory diseases. Expert Opin. Biol. Ther.7(9), 1449–1461 (2007).
  • Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. Respiratory epithelial cells convert inactive vitamin-D to its active form: potential effects on host defense. J. Immunol.181(10), 7090–7099 (2008).
  • Helming L, Bose J, Ehrchen J et al. 1α,25-dihydroxyvitamin-D3 is a potent suppressor of interferon γ-mediated macrophage activation. Blood106(13), 4351–4358 (2005).
  • Aloia JF, Li-Ng M. Re: epidemic influenza and vitamin-D. Epidemiol. Infect.135(7), 1095–1096; author reply 1097–1098 (2007).
  • Grant WB. Hypothesis – ultraviolet-B irradiance and vitamin-D reduce the risk of viral infections and thus their sequelae, including autoimmune diseases and some cancers. Photochem. Photobiol.84(2), 356–365 (2008).
  • Cannell JJ, Vieth R, Umhau JC et al. Epidemic influenza and vitamin-D. Epidemiol. Infect.134(6), 1129–1140 (2006).
  • Cannell JJ, Zasloff M, Garland CF, Scragg R, Giovannucci E. On the epidemiology of influenza. Virol. J.5, 29 (2008).
  • Li-Ng M, Aloia JF, Pollack S et al. A randomized controlled trial of vitamin-D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol. Infect.137(10), 1396–1404 (2009).
  • Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of vitamin-D3 intake exceeding the lowest observed adverse effect level. Am. J. Clin. Nutr.73(2), 288–294 (2001).
  • Yamshchikov AV, Desai NS, Blumberg HM, Ziegler TR, Tangpricha V. Vitamin-D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr. Pract.15(5), 438–449 (2009).
  • Wejse C, Gomes VF, Rabna P et al. Vitamin-D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am. J. Respir. Crit. Care Med.179(9), 843–850 (2009).
  • Ginde AA, Mansbach JM, Camargo CA Jr. Vitamin-D, respiratory infections, and asthma. Curr. Allergy Asthma Rep.9(1), 81–87 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.